Michel L Campos

Dr. Michel L Campos

Health Sciences Institute, Universidade Federal de Mato Grosso, Sinop, Mato Grosso, Brazil
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
VGVânia Ortega Gutierres
Vânia Ortega Gutierres
MCMichel L Campos
Michel L Campos
CACarlos Alberto Arcaro
Carlos Alberto Arcaro
RARenata Assis
Renata Assis
HBHelen Mariana Baldan-Cimatti
Helen Mariana Baldan-Cimatti
IBIguatemy Lourenço Brunetti
Iguatemy Lourenço Brunetti
This study measures the curcumin concentration in rat plasma by liquid chromatography and investigates the changes in the glucose tolerance and insulin sensitivity of streptozotocin-diabetic rats treated with curcumin-enriched yoghurt. The analytical method for curcumin detection was linear from 10 to 500 ng/mL. TheCmax⁡and the time to reachCmax⁡(tmax⁡) of curcumin in plasma were 3.14 ± 0.9 μg/mL and 5 minutes (10 mg/kg, i.v.) and 0.06 ± 0.01 μg/mL and 14 minutes (500 mg/kg, p.o.). The elimination half-time was 8.64 ± 2.31 ​​(i.v.) and 32.70 ± 12.92 (p.o.) minutes. The oral bioavailability was about 0.47%. Changes in the glucose tolerance and insulin sensitivity were investigated in four groups: normal and diabetic rats treated with yoghurt (NYOG and DYOG, resp.) and treated with 90 mg/kg/day curcumin incorporated in yoghurt (NC90 and DC90, resp.). After 15 days of treatment, the glucose tolerance and the insulin sensitivity were significantly improved in DC90 rats in comparison with DYOG, which can be associated with an increase in the AKT phosphorylation levels and GLUT4 translocation in skeletal muscles. These findings can explain, at least in part, the benefits of curcumin-enriched yoghurt to diabetes and substantiate evidences for the curcumin metabolite(s) as being responsible for the antidiabetic activity.

1 May 2013 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
FCFlávia Carvalho
Flávia Carvalho
MCMichel L Campos
Michel L Campos
RPRosângela Gonçalves Peccinini
Rosângela Gonçalves Peccinini
MGMaria Palmira Daflon Gremião
Maria Palmira Daflon Gremião

4 December 2015 in Analytical Chemistry
Verified
Journal Article
Closed access
ATAlessandra Tata
Alessandra Tata
CPConsuelo Perez
Consuelo Perez
MCMichel L Campos
Michel L Campos
MBMark A. Bayfield
Mark A. Bayfield
MEMarcos N. Eberlin
Marcos N. Eberlin
DIDemian R. Ifa
Demian R. Ifa

24 October 2016 in Journal of the American Society for Mass Spectrometry
Verified
Journal Article
Closed access
CPConsuelo J. Perez
Consuelo J. Perez
ATAlessandra Tata
Alessandra Tata
MCMichel L Campos
Michel L Campos
CPChun Peng
Chun Peng
DIDemian R. Ifa
Demian R. Ifa

3 November 2017 in Molecules
Verified
Journal Article
Open access
PDF file
CMCleverson Antonio Ferreira Martins
Cleverson Antonio Ferreira Martins
MCMichel L Campos
Michel L Campos
AIAna Carolina Irioda
Ana Carolina Irioda
DSDile Pontarolo Stremel
Dile Pontarolo Stremel
ATAngela Cristina Leal Badaró Trindade
Angela Cristina Leal Badaró Trindade
RPRoberto Pontarolo
Roberto Pontarolo
The ability of plant extracts and preparations to reduce inflammation has been proven by different means in experimental models. Since inflammation enhances the release of specific mediators, inhibition of their production can be used to investigate the anti-inflammatory effect of plants widely used in folk medicine for this purpose. The study was performed for leaves and flowers of Malva sylvestris, and leaves of Sida cordifolia and Pelargonium graveolens. These are three plant species known in Brazil as Malva. The anti-inflammatory activity of extracts and fractions (hexane, chloroform, ethyl acetate, and residual) was evaluated by quantitation of prostaglandins (PG) PGE2, PGD2, PGF2α, and thromboxane B2 (the stable nonenzymatic product of TXA2) concentration in the supernatant of lipopolysaccharide (LPS)- induced RAW 264.7 cells. Inhibition of anti-inflammatory mediator release was observed for plants mainly in the crude extract, ethyl acetate fraction, and residual fraction. The results suggest superior activity of S. cordifolia, leading to significantly lower values of all mediators after treatment with its residual fraction, even at the lower concentration tested (10 μg/mL). M. sylvestris and P. graveolens showed similar results, such as the reduction of all mediators after treatment, with leaf crude extracts (50 μg/mL). These results suggest that the three species known as Malva have anti-inflammatory properties, S. cordifolia being the most potent.

1 November 2019 in Cytokine
Verified
Journal Article
Closed access
NLNatalia Da Ponte Leguizamón
Natalia Da Ponte Leguizamón
ERElisandra Marcia Rodrigues
Elisandra Marcia Rodrigues
MCMichel L Campos
Michel L Campos
ANAndressa Vilas Boas Nogueira
Andressa Vilas Boas Nogueira
KVKennia Scapin Viola
Kennia Scapin Viola
JCJoni AUGUSTO CIRELLI
Joni AUGUSTO CIRELLI